Mineralys Therapeutics MLYS - オプションチェーン | ADVFN

US Dollar vs Yen

登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。

登録

ホーム
投資
株式
アメリカ
NASDAQ
Mineralys Therapeutics Inc (MLYS)
Mineralys Therapeutics Inc (MLYS) オプション

Mineralys Therapeutics Inc (MLYS)

10.24

0.04

(0.39%)

終了 2月15日 6:00AM

10.24

0.00

( 0.00% )

プレマーケット: 6:32PM

MLYS ライブオプションフロー

オプションコール

行使価格	買値	売値	前回の価格	中間価格	前日比	前日比 %	出来高	建玉	最終取引
2.50	5.50	10.00	0.00	7.75	0.00	0.00 %	0	0	-
5.00	3.00	7.50	0.00	5.25	0.00	0.00 %	0	0	-
7.50	0.50	5.00	0.00	2.75	0.00	0.00 %	0	0	-
10.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
12.50	1.50	1.50	1.50	1.50	0.00	0.00 %	0	10	-
15.00	0.70	4.90	0.70	2.80	0.00	0.00 %	0	6	-
17.50	0.65	4.90	0.65	2.775	0.00	0.00 %	0	12	-
20.00	0.00	4.90	0.00	0.00	0.00	0.00 %	0	0	-

リアルタイムのストリーミング引用、アイデア、ライブディスカッションのハブ

プレミアム

オプションプット

行使価格	買値	売値	前回の価格	中間価格	前日比	前日比 %	出来高	建玉	最終取引
2.50	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
5.00	0.00	0.20	0.00	0.00	0.00	0.00 %	0	0	-
7.50	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
10.00	1.00	1.00	1.00	1.00	0.00	0.00 %	0	10	-
12.50	1.65	1.65	1.65	1.65	0.00	0.00 %	0	7	-
15.00	3.50	3.50	3.50	3.50	0.00	0.00 %	0	5	-
17.50	5.00	9.50	0.00	7.25	0.00	0.00 %	0	0	-
20.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-

出来高
値上がり率
値下がり率

銘柄コード	株価	出来高
EFOIEnergy Focus Inc	US$ 2.33 (80.62%)	3.03M
GLYCGlycoMimetics Inc	US$ 0.4789 (65.14%)	9.74M
FSFGFirst Savings Financial Group Inc	US$ 37.00 (49.07%)	104
ADTXAditxt Inc	US$ 0.0961 (37.29%)	35.25M
TNMGTNL Mediagene	US$ 3.10 (34.20%)	3.45k
RSLSReShape Lifesciences Inc	US$ 0.8105 (-65.21%)	161.05k
LEELee Enterprises Inc	US$ 7.00 (-38.92%)	100
NTICNorthern Technologies International Corporation	US$ 7.00 (-37.94%)	102
INLFINLIF Limited	US$ 11.88 (-27.25%)	10.14k
MGOLMGO Global Inc	US$ 0.5696 (-20.62%)	4.42M
ADTXAditxt Inc	US$ 0.0961 (37.29%)	35.25M
GLYCGlycoMimetics Inc	US$ 0.4789 (65.14%)	9.74M
EDBLEdible Garden AG Inc	US$ 0.2519 (25.01%)	5.31M
MGOLMGO Global Inc	US$ 0.5696 (-20.62%)	4.42M
DGLYDigital Ally Inc	US$ 0.0835 (8.87%)	4.15M

TheFinalCD

TheFinalCD 7分前

https://x.com/Beppels1/status/1890449070923141202

The ELTP King

The ELTP King 8分前

Both are happening.

Nasdaq then buyout.

His intention is to suggest with certainty that we are headed for a reverse split and not a buyout.

TheFinalCD

TheFinalCD 9分前

GOOD CALL

GLYC BELL BUY INTO VOLUME AND BIG GAPPER

Cflores32097

Cflores32097 9分前

btw FP still owes all those investors he robbed

somberfox

somberfox 13分前

somberfox

somberfox 14分前

Cflores32097

Cflores32097 14分前

Oh yea 🦆🦆 is so 2022 we got a new scam

Cflores32097

Cflores32097 14分前

Hey Charles, what happened 🦆 🦆 go

Cflores32097

Cflores32097 15分前

LIONS GROUP CBD EVANS CYBER ZEN

Cflores32097

Cflores32097 18分前

Jzzi CBD HONEY GREG EVANS 55 UP

WolfofMia

WolfofMia 28分前

You don't have the energy, except for pompous reasons.

Got it.

longview1

longview1 28分前

My post keep getting removed, obviously making one of the Trump babies mad.

Dragonman1

Dragonman1 34分前

I hope we all benefit from this great beer co and see the awesome results in the report coming out soon, The bashers or the fool force is in for a big wake up call, northbound we go!

NickyCapone

NickyCapone 38分前

Warning‼️
All Shorties‼️

Last One Out is a Rotten Egg‼️

lakers17

lakers17 43分前

Yeah I feel the same way recently. Both the OTC and crypto are pissing me off. I keep buying more and more crypto on many of these dips. It's really boom or bust for me.

Guzzi62

Guzzi62 46分前

The main trial didn't fail dude, one primary endpoint failed, which is not the same.

That endpoint is in the process of being removed by the FDA which you likely knew already.

Why are you lying?

king_kong

king_kong 49分前

https://x.com/maxinvestor89/status/1891752794396229705?s=46&t=He3ILIizDMal7FFXIIgFjw

sharkey1

sharkey1 51分前

Correction, on the house bill 1396, copied from redit,

https://www.reddit.com/r/WallStreetbetsELITE/comments/1irl3m7/how_hr1396_could_impact_the_stock_market_generic/

can't find on google, it's in the ways and means committee
I think

capgain

capgain 52分前

Good morning, Larry, the cold is returning again.

walterc

walterc 53分前

mailconversation with IR
read the reply
- Appreciate your patience as we've worked to get you answers to some of these questions. Management is not in a position to provide an update on the commercial strategy with firm targets, timelines, etc. as that would constitute a material upda

valleybenedetto

valleybenedetto 53分前

There is ZERO dilution here. No warrants no overhead supply.

capgain

capgain 53分前

Happy Birthday, B2B!

DJPele

DJPele 55分前

Interesting update on the biosimilar candidate FYB206 with Merck's Keytruda:

"Regulatory developments in the U.S. indicate that the framework conditions for biosimilars continue to improve. The FDA has confirmed that extensive analytical data, together with the ongoing phase I trial,

SkeBallLarry

SkeBallLarry 55分前

*Super* " Happy BirthDay, back2basics " ..!!

NickyCapone

NickyCapone 56分前

Shortie is DOOMED‼️

Rude Awaking‼️

MOASS Alert 🚨 ‼️

Ring the Bell 🛎️ ‼️

Mineralys Therapeutics

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約